Showing results (101-110 of 205) with videos related to
Sort By:
Pageof 21
Journal of Fungi (Basel, Switzerland)|December 22, 2023
Isolation of Yeast Strains with Higher Proline Uptake and Their Applications to Beer FermentationRyoya Tanahashi, Akira Nishimura, Minh Nguyen, et al.Brain & Development|May 21, 2008
Plasticity and injury in the developing brainMichael V Johnston, Akira Ishida, Wako Nakajima Ishida, et al.Bioscience, Biotechnology, and Biochemistry|December 10, 2022
Large-scale screening of yeast strains that can utilize prolineRyoya Tanahashi, Akira Nishimura, Minh Nguyen, et al.Brain & Development|May 30, 2009
A case of Baraitser-Winter syndrome with unusual brain MRI findings: pachygyria, subcortical-band heterotopia, and periventricular heterotopiaTakashi Shiihara, Ken-ichi Maruyama, Yoshiyuki Yamada, et al.Brain & Development|May 20, 2018
Cerebellar peduncle injury predicts motor impairments in preterm infants: A quantitative tractography study at term-equivalent ageTatsuji Hasegawa, Kei Yamada, Takenori Tozawa, et al.Neuropediatrics|January 5, 2018
A 5-Year Follow-Up of Triple-Seronegative Myasthenia Gravis Successfully Treated with Tacrolimus TherapyTakenori Tozawa, Akira Nishimura, Tamaki Ueno, et al.Brain & Development|June 30, 2014
A de novo TUBB4A mutation in a patient with hypomyelination mimicking Pelizaeus-Merzbacher diseaseKeiko Shimojima, Akihisa Okumura, Mitsuru Ikeno, et al.Clinical Journal of Gastroenterology|July 31, 2025
Delayed recurrence of hepatitis E virus RNA in serum and feces after ribavirin therapy for chronic hepatitis E: importance of extended follow-upHiroshi Okano, Minoru Mizutani, Keiki Kawakami, et al.Gut|October 9, 2017
Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension studyYuji Mizokami, Kazunori Oda, Nobuo Funao, et al.Parkinsonism & Related Disorders|May 12, 2018
Efficacy and safety of adjunctive rasagiline in Japanese Parkinson's disease patients with wearing-off phenomena: A phase 2/3, randomized, double-blind, placebo-controlled, multicenter studyNobutaka Hattori, Atsushi Takeda, Shinichi Takeda, et al.Pageof 21